Dexcel Pharma patents expiration
1. Omeprazole patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9023391 | DEXCEL PHARMA | Stable benzimidazole formulation |
Aug, 2025
(1 year, 3 months from now) | |
Drugs and Companies using OMEPRAZOLE ingredient
Market Authorisation Date: 04 December, 2007
Treatment: NA
Dosage: TABLET, DELAYED RELEASE;ORAL
More Information on Dosage
OMEPRAZOLE family patents
